What is Microsonic?
Established in 1964, Microsonic has cultivated a reputation as a leading full-service earmold laboratory, recognized for its commitment to quality service, craftsmanship, products, and materials. The company specializes in producing high-quality earmolds, meticulously crafted to dispenser specifications using only the finest available materials. Microsonic's dedication to innovation is evident in its development of proprietary products such as the tragus earmold, stethoscope adapter mold, and advanced design free field mold. Furthermore, the company holds patents for the Tube Lock Plus and the Microsonic Universal Syringe, alongside a design patent for its SOLOS packaging. Microsonic also plays a crucial role as a major supplier of impression materials, fitting supplies, office tools, accessories, and preformed earmold tubing, serving as a comprehensive resource for the industry.
How much funding has Microsonic raised?
Microsonic has raised a total of $423K across 2 funding rounds:
Debt
$150K
Debt
$273K
Debt (2020): $150K with participation from PPP
Debt (2021): $273K led by PPP
Key Investors in Microsonic
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Microsonic?
The recent major strategic investment indicates Microsonic is likely in a growth or scaling phase, leveraging this capital to further its market leadership and potentially expand its product development and material research initiatives. Given its extensive history and established market position, this financing could be directed towards enhancing manufacturing capabilities, exploring new material technologies, or broadening its distribution channels for both its laboratory services and its extensive accessory division. The company's consistent focus on quality and innovation suggests a strategic deployment of these funds to maintain its competitive edge and continue its legacy of excellence in the audiology supply chain.
See full Microsonic company page
